EGF and hepatocellular carcinoma: EGFR, a member of the receptor tyrosine kinase (RTK) family, is frequently presented in HCC patients, and the activation of the EGF/EGFR signaling pathway is closely related to aggressive, intrahepatic metastasis, and poor clinical outcome9.